The Novel, Irreversible Proteasome Inhibitor PR-171 Demonstrates Potent Anti-Tumor Activity in Pre-Clinical Models of Multiple Myeloma, and Overcomes Bortezomib Resistance.
- Resource Type
- Abstract
- Source
- In
Blood 16 November 2006 108(11):3461-3461 - Subject
- Language
- ISSN
- 0006-4971